Status:
ACTIVE_NOT_RECRUITING
3 Tesla MRI in Patients With Bladder Cancer
Lead Sponsor:
University of Cincinnati
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease. PURPOSE: This clinical trial is studying how well...
Detailed Description
OBJECTIVES: Primary * To evaluate whether 3 Tesla MRI can accurately determine the primary tumor (T) stage and pelvic lymph nodes (N) stage in patients with localized bladder cancer as compared to h...
Eligibility Criteria
Inclusion
- Known bladder cancer
- Scheduled for radical cystectomy and lymph node dissection.
- Able and willing to give valid written informed consent.
- No contraindications to the MRI(magnetic resonance imaging).
Exclusion
- Not pregnant, planning to become pregnant during the study, or nursing.
- No allergy to contrast agents.
- Patient with significant renal insufficiency, i.e. an estimated glomerular filtration rate(eGRF) less than 30 mL/min/1.73m2.
- Any condition conflict based on the investigation's clinical judgment that would prevent the patient from completion all trial assessments and visits.
- Inability or unwillingness to cooperate with requirements of this trial.
- Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe vertigo when they are moved into the MR.
- Patients with sickle cell anemia and other hemolytic anemia.
Key Trial Info
Start Date :
July 8 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00938145
Start Date
July 8 2009
End Date
December 31 2026
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Medical Center
Columbus, Ohio, United States, 43210